SCHEMBL17170371

SCHEMBL17170371

c1ccc(-n2c3ccccc3c3cc4c(cc32)Oc2cc(-c3ccc5oc6ccccc6c5c3)ccc2O4)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.43
▸ ATM Q13315 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ EDNRA P25101 5/20 0.35
▸ EDNRB P24530 1/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PLA2G2A P14555 3/20 0.34
▸ PLA2G4A P47712 3/20 0.34
▸ PLA2G10 O15496 1/20 0.33
▸ AHR P35869 1/20 0.33
▸ SIRT2 Q8IXJ6 1/20 0.32
▸ SIRT1 Q96EB6 1/20 0.32
▸ PTGER4 P35408 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14733861 0.90 KDM4E (0.53) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL26725474 0.90 KDM4E (0.53) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL15630689 0.90 KDM4E (0.53) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL12159670 0.90 KDM4E (0.53) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL18622771 0.89 EDNRA (0.38) KDM4EATML3MBTL1EDNRAEDNRB
SCHEMBL26060121 0.89 KDM4E (0.49) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL18381747 0.89 KDM4E (0.51) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL20706816 0.89 KDM4E (0.51) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL19830320 0.88 KDM4E (0.47) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL19830411 0.88 KDM4E (0.47) KDM4EATML3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10756277-B2 Organic compound and organic electroluminescent device comprising the same DOOSAN SOLUS CO., LTD. (KR) 2020-08-25 — — US disclosed
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2017-06-15 — — US disclosed
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2017-06-15 — — US disclosed
WO-2015156580-A2 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 주식회사 두산 2015-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170170406-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OR10J3, ORC3, L1CAM KDM4E 909/4885ATM 1000/4885L3MBTL1 609/4885
US-10756277-B2 Organic compound and organic electroluminescent device comprising the same OR10J3, L1CAM, ICOSLG KDM4E 953/4885ATM 1280/4885L3MBTL1 314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback